Abbott Nutrition has received FDA approval to resume production of EleCare infant formula for children with poor digestion at a plant in Michigan. The first batch will be released on June 20 this year. Earlier, the FDA initiated an investigation after 4 infants were hospitalized with bacterial infections caused by the company's powdered milk formula.